The low FODMAP diet: Recent advances in understanding its mechanisms and efficacy in IBS

Gut

Volumn 66, Issue 8, 2017, Pages 1517-1527

  Staudacher, Heidi M ^a   Whelan, Kevin ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

colonic microflora; diet; intestinal microbiology; irritable bowel syndrome

Indexed keywords

DISACCHARIDE; FRUCTOSE; GLUTEN; INULIN; MONOSACCHARIDE; OLIGOSACCHARIDE; PLACEBO; POLYOL; PREBIOTIC AGENT; PROBIOTIC AGENT; SHORT CHAIN FATTY ACID; SMALL INTESTINAL WATER; UNCLASSIFIED DRUG; WATER;

ABDOMINAL PAIN; ARTICLE; BACTEROIDES; BLOATING; CLINICAL EFFECTIVENESS; CLOSTRIDIUM; COLONIC GAS PRODUCTION; CONSTIPATION; DIARRHEA; DIET RESTRICTION; DIET THERAPY; DIGESTIVE SYSTEM EXAMINATION; FAECALIBACTERIUM PRAUSNITZII; FERMENTATION; FOOD INTAKE; GAS; GASTROINTESTINAL TRANSIT; HEALTH HAZARD; HIGH FIBER DIET; HUMAN; IBS SEVERITY SCORING SCALE; INTESTINE FLORA; IRRITABLE COLON; LACTOBACILLUS; LIFESTYLE MODIFICATION; LOW FERMENTABLE OLIGOSACCHARIDE, DISACCHARIDE, MONOSACCHARIDE AND POLYOL DIET; METABOLOMICS; MICROBIOME; NUTRIENT INTAKE; NUTRITIONAL COUNSELING; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); RUMINOCOCCACEAE; TREATMENT DURATION; TREATMENT RESPONSE; BODY WATER; CALORIC INTAKE; CARBOHYDRATE DIET; CARBOHYDRATE METABOLISM; COLON; COMPLICATION; DIET; DIETARY FIBER; METABOLISM; SMALL INTESTINE;

BODY WATER; CARBOHYDRATE METABOLISM; COLON; DIARRHEA; DIET; DIETARY CARBOHYDRATES; DIETARY FIBER; ENERGY INTAKE; FERMENTATION; GASES; GASTROINTESTINAL MICROBIOME; HUMANS; INTESTINE, SMALL; IRRITABLE BOWEL SYNDROME; RANDOMIZED CONTROLLED TRIALS AS TOPIC;

EID: 85024408277     PISSN: 00175749     EISSN: 14683288     Source Type: Journal    
DOI: 10.1136/gutjnl-2017-313750     Document Type: Article

References (88)

1. Mearin F, Lacy BE, Chang L, et al. Bowel disorders. Gastroenterology 2016;150:1393-407.
2. Lovell RM, Ford AC. Global prevalence of and risk factors for irritable bowel syndrome: A meta-Analysis. Clin Gastroenterol Hepatol 2012;10:712-21.
3. Yao X, Yang YS, Cui LH, et al. Subtypes of irritable bowel syndrome on Rome III criteria: A multicenter study. J Gastroenterol Hepatol 2012;27:760-5.
4. Engsbro AL, Simren M, Bytzer P. Short-Term stability of subtypes in the irritable bowel syndrome: prospective evaluation using the Rome III classification. Aliment Pharmacol Ther 2012;35:350-9.
5. Pinto-Sanchez MI, Ford AC, Avila CA, et al. Anxiety and depression increase in a stepwise manner in parallel with multiple FGIDs and symptom severity and frequency. Am J Gastroenterol 2015;110:1038-48.
6. Gralnek IM, Hays RD, Kilbourne A, et al. The impact of irritable bowel syndrome on health-related quality of life. Gastroenterology 2000;119:654-60.
7. Mönnikes H. Quality of life in patients with irritable bowel syndrome. J Clin Gastroenterol 2011;45:S98-S101.
8. Thompson WG, Heaton KW, Smyth GT, et al. Irritable bowel syndrome in general practice: prevalence, characteristics, and referral. Gut 2000;46:78-82.
9. Jones J, Boorman J, Cann P, et al. British society of Gastroenterology guidelines for the management of the irritable bowel syndrome. Gut 2000;47:1ii-19.
10. Canavan C, West J, Card T. Review article: The economic impact of the irritable bowel syndrome. Aliment Pharmacol Ther 2014;40:1023-34.
11. Maxion-Bergemann S, Thielecke F, Abel F, et al. Costs of irritable bowel syndrome in the UK and US. Pharmacoeconomics 2006;24:21-37.
12. Chang L, Lembo A, Sultan S. American Gastroenterological Association Institute Technical Review on the pharmacological management of irritable bowel syndrome. Gastroenterology 2014;147:1149-72.
13. Monsbakken KW, Vandvik PO, Farup PG. Perceived food intolerance in subjects with irritable bowel syndrome-etiology, prevalence and consequences. Eur J Clin Nutr 2006;60:667-72.
14. Böhn L, Störsrud S, Simrén M. Nutrient intake in patients with irritable bowel syndrome compared with the general population. Neurogastroenterol Motil 2013;25:23-30.e1.
15. McKenzie YA, Bowyer RK, Leach H, et al. British dietetic association systematic review and evidence-based practice guidelines for the dietary management of irritable bowel syndrome in adults (2016 update). J Hum Nutr Diet 2016;29:549-75.
16. Moayyedi P, Quigley EM, Lacy BE, et al. The effect of fiber supplementation on irritable bowel syndrome: A systematic review and meta-Analysis. Am J Gastroenterol 2014;109:1367-74.
17. Nagarajan N, Morden A, Bischof D, et al. The role of fiber supplementation in the treatment of irritable bowel syndrome: A systematic review and meta-Analysis. Eur J Gastroenterol Hepatol 2015;27:1002-10.
18. Hayes P, Corish C, OMahony E, et al. A dietary survey of patients with irritable bowel syndrome. J Hum Nutr Diet 2014;27:36-47.
19. Reding KW, Cain KC, Jarrett ME, et al. Relationship between patterns of alcohol consumption and gastrointestinal symptoms among patients with irritable bowel syndrome. Am J Gastroenterol 2013;108:270-6.
20. Aziz I, Trott N, Briggs R, et al. Efficacy of a gluten-free diet in subjects with irritable bowel syndrome-diarrhea unaware of their HLA-DQ2/8 genotype. Clin Gastroenterol Hepatol 2016;14:696-703.
21. Wahnschaffe U, Schulzke JD, Zeitz M, et al. Predictors of clinical response to glutenfree diet in patients diagnosed with diarrhea-predominant irritable bowel syndrome. Clin Gastroenterol Hepatol 2007;5:844-50.
22. Vazquez-Roque MI, Camilleri M, Smyrk T, et al. A controlled trial of gluten-free diet in patients with irritable bowel syndrome-diarrhea: effects on bowel frequency and intestinal function. Gastroenterology 2013;144:903-11.
23. Biesiekierski JR, Peters SL, Newnham ED, et al. No effects of gluten in patients with self-reported non-celiac gluten sensitivity after dietary reduction of fermentable, poorly absorbed, short-chain carbohydrates. Gastroenterology 2013;145:320-8.e1-3.
24. Nanda R, James R, Smith H, et al. Food intolerance and the irritable bowel syndrome. Gut 1989;30:1099-104.
25. Parker TJ, Naylor SJ, Riordan AM, et al. Management of patients with food intolerance in irritable bowel syndrome: The development and use of an exclusion diet. J Hum Nutr Diet 1995;8:159-66.
26. Fritscher-Ravens A, Schuppan D, Ellrichmann M, et al. Confocal endomicroscopy shows food-Associated changes in the intestinal mucosa of patients with irritable bowel syndrome. Gastroenterology 2014;147:1012-20.
27. Ford AC, Quigley EM, Lacy BE, et al. Efficacy of prebiotics, probiotics, and synbiotics in irritable bowel syndrome and chronic idiopathic constipation: systematic review and meta-Analysis. Am J Gastroenterol 2014;109:1547-61.
28. McKenzie YA, Thompson J, Gulia P, et al. British dietetic association systematic review of systematic reviews and evidence-based practice guidelines for the use of probiotics in the management of irritable bowel syndrome in adults (2016 update). J Hum Nutr Diet 2016;29:576-92.
29. Staudacher HM, Irving PM, Lomer MC, et al. Mechanisms and efficacy of dietary FODMAP restriction in IBS. Nat Rev Gastroenterol Hepatol 2014;11:256-66.
30. Elia M, Cummings JH. Physiological aspects of energy metabolism and gastrointestinal effects of carbohydrates. Eur J Clin Nutr 2007;61:S40-S74.
31. Scott KP, Gratz SW, Sheridan PO, et al. The influence of diet on the gut microbiota. Pharmacol Res 2013;69:52-60.
32. Hernot DC, Boileau TW, Bauer LL, et al. In vitro fermentation profiles, gas production rates, and microbiota modulation as affected by certain fructans, galactooligosaccharides, and polydextrose. J Agric Food Chem 2009;57:1354-61.
33. Evans PR, Piesse C, Bak YT, et al. Fructose-sorbitol malabsorption and symptom provocation in irritable bowel syndrome: relationship to enteric hypersensitivity and dysmotility. Scand J Gastroenterol 1998;33:1158-63.
34. Gudmand-Høyer E. The clinical significance of disaccharide maldigestion. Am J Clin Nutr 1994;59:735S-41S.
35. Shepherd SJ, Parker FC, Muir JG, et al. Dietary triggers of abdominal symptoms in patients with irritable bowel syndrome: randomized placebo-controlled evidence. Clin Gastroenterol Hepatol 2008;6:765-71.
36. Barrett JS, Gearry RB, Muir JG, et al. Dietary poorly absorbed, short-chain carbohydrates increase delivery of water and fermentable substrates to the proximal colon. Aliment Pharmacol Ther 2010;31:874-82.
37. Marciani L, Cox EF, Hoad CL, et al. Postprandial changes in small bowel water content in healthy subjects and patients with irritable bowel syndrome. Gastroenterology 2010;138:469-77.
38. Murray K, Wilkinson-Smith V, Hoad C, et al. Differential effects of FODMAPs (fermentable oligo-, di-, mono-saccharides and polyols) on small and large intestinal contents in healthy subjects shown by MRI. Am J Gastroenterol 2014;109:110-9.
39. Major G, Pritchard S, Murray K, et al. Colon hypersensitivity to distension, rather than excessive gas production, produces carbohydrate-related symptoms in individuals with irritable bowel syndrome. Gastroenterology 2017;152:124-33.
40. Spiller RC, Brown ML, Phillips SF. Decreased fluid tolerance, accelerated transit, and abnormal motility of the human colon induced by oleic acid. Gastroenterology 1986;91:100-7.
41. Ong DK, Mitchell SB, Barrett JS, et al. Manipulation of dietary short chain carbohydrates alters the pattern of gas production and genesis of symptoms in irritable bowel syndrome. J Gastroenterol Hepatol 2010;25:1366-73.
42. McIntosh K, Reed DE, Schneider T, et al. FODMAPs alter symptoms and the metabolome of patients with IBS: A randomised controlled trial. Gut 2016:gutjnl-2015-311339 (Published Online First: 14 Mar 2016).
43. Madsen JL, Linnet J, Rumessen JJ. Effect of nonabsorbed amounts of a fructosesorbitol mixture on small intestinal transit in healthy volunteers. Dig Dis Sci 2006;51:147-53.
44. Halmos EP, Christophersen CT, Bird AR, et al. Diets that differ in their FODMAP content alter the colonic luminal microenvironment. Gut 2015;64:93-100.
45. Tana C, Umesaki Y, Imaoka A, et al. Altered profiles of intestinal microbiota and organic acids may be the origin of symptoms in irritable bowel syndrome. Neurogastroenterol Motil 2010;22:512-9.e114-5.
46. Bourdu S, Dapoigny M, Chapuy E, et al. Rectal instillation of butyrate provides a novel clinically relevant model of noninflammatory colonic hypersensitivity in rats. Gastroenterology 2005;128:1996-2008.
47. Valeur J, Røseth AG, Knudsen T, et al. Fecal fermentation in irritable bowel syndrome: influence of dietary restriction of fermentable oligosaccharides, disaccharides, monosaccharides and polyols. Digestion 2016;94:50-6.
48. Hustoft TN, Hausken T, Ystad SO, et al. Effects of varying dietary content of fermentable short-chain carbohydrates on symptoms, fecal microenvironment, and cytokine profiles in patients with irritable bowel syndrome. Neurogastroenterol Motil 2017;29:e12969.
49. Staudacher HM, Lomer M, Louis P, et al. 1133 the low FODMAP diet reduces symptoms in irritable bowel syndrome compared with placebo diet and the microbiota alterations may be prevented by probiotic co-Administration: A 2x2 factorial randomized controlled trial. Gastroenterology 2016;150:S230.
50. Staudacher HM, Lomer MC, Anderson JL, et al. Fermentable carbohydrate restriction reduces luminal bifidobacteria and gastrointestinal symptoms in patients with irritable bowel syndrome. J Nutr 2012;142:1510-8.
51. Duncan SH, Holtrop G, Lobley GE, et al. Contribution of acetate to butyrate formation by human faecal bacteria. Br J Nutr 2004;91:915-23.
52. Ringel-Kulka T, Choi CH, Temas D, et al. Altered colonic bacterial fermentation as a potential pathophysiological factor in irritable bowel syndrome. Am J Gastroenterol 2015;110:1339-46.
53. Cummings JH, Macfarlane GT. The control and consequences of bacterial fermentation in the human colon. J Appl Bacteriol 1991;70:443-59.
54. Millet S, Van Oeckel MJ, Aluwé M, et al. Prediction of in vivo short-chain fatty acid production in hindgut fermenting mammals: problems and pitfalls. Crit Rev Food Sci Nutr 2010;50:605-19.
55. Mazzawi T, Hausken T, Gundersen D, et al. Dietary guidance normalizes large intestinal endocrine cell densities in patients with irritable bowel syndrome. Eur J Clin Nutr 2016;70:175-81.
56. Zhou S-Y, Eswaran SL, Wu X, et al. 261 low FODMAP diet modulates visceral nociception by changing gut microbiota and intestinal permeability in IBS. Gastroenterology 2016;150:S63-S64.
57. Öhman L, Törnblom H, Simrén M. Crosstalk at the mucosal border: importance of the gut microenvironment in IBS. Nat Rev Gastroenterol Hepatol 2015;12:36-49.
58. Rao SS, Yu S, Fedewa A. Systematic review: dietary fibre and FODMAP-restricted diet in the management of constipation and irritable bowel syndrome. Aliment Pharmacol Ther 2015;41:1256-70.
59. Marsh A, Eslick EM, Eslick GD. Does a diet low in FODMAPs reduce symptoms associated with functional gastrointestinal disorders? A comprehensive systematic review and meta-Analysis. Eur J Nutr 2016;55:897-906.
60. Staudacher HM, Whelan K, Irving PM, et al. Comparison of symptom response following advice for a diet low in fermentable carbohydrates (FODMAPs) versus standard dietary advice in patients with irritable bowel syndrome. J Hum Nutr Diet 2011;24:487-95.
61. Whigham L, Joyce T, Harper G, et al. Clinical effectiveness and economic costs of group versus one-To-one education for short-chain fermentable carbohydrate restriction (low FODMAP diet) in the management of irritable bowel syndrome. J Hum Nutr Diet 2015;28:687-96.
62. Shepherd SJ, Gibson PR. Fructose malabsorption and symptoms of irritable bowel syndrome: guidelines for effective dietary management. J Am Diet Assoc 2006;106:1631-9.
63. Maagaard L, Ankersen DV, Végh Z, et al. Follow-up of patients with functional bowel symptoms treated with a low FODMAP diet. World J Gastroenterol 2016;22:4009-19.
64. Prince AC, Myers CE, Joyce T, et al. Fermentable Carbohydrate restriction (Low FODMAP Diet) in clinical practice improves functional gastrointestinal symptoms in patients with inflammatory bowel disease. Inflamm Bowel Dis 2016;22:1129-36.
65. Wilder-Smith CH, Materna A, Wermelinger C, et al. Fructose and lactose intolerance and malabsorption testing: The relationship with symptoms in functional gastrointestinal disorders. Aliment Pharmacol Ther 2013;37:1074-83.
66. de Roest RH, Dobbs BR, Chapman BA, et al. The low FODMAP diet improves gastrointestinal symptoms in patients with irritable bowel syndrome: A prospective study. Int J Clin Pract 2013;67:895-903.
67. Mazzawi T, Hausken T, Gundersen D, et al. Effects of dietary guidance on the symptoms, quality of life and habitual dietary intake of patients with irritable bowel syndrome. Mol Med Rep 2013;8:845-52.
68. Ostgaard H, Hausken T, Gundersen D, et al. Diet and effects of diet management on quality of life and symptoms in patients with irritable bowel syndrome. Mol Med Rep 2012;5:1382-90.
69. Harvie R, Chisholm A, Schultz M. A reduction in FODMAP intake correlates strongly with a reduction in IBS symptoms: The FIBS study. J Gastroenterol Hepatol 2013;28:352.
70. Eswaran SL, Chey WD, Han-Markey T, et al. A randomized controlled trial comparing the low FODMAP diet vs. Modified NICE guidelines in US adults with IBS-D. Am J Gastroenterol 2016;111:1824-32.
71. Peters SL, Yao CK, Philpott H, et al. Randomised clinical trial: The efficacy of gutdirected hypnotherapy is similar to that of the low FODMAP diet for the treatment of irritable bowel syndrome. Aliment Pharmacol Ther 2016;44:447-59.
72. Elsenbruch S, Enck P. Placebo effects and their determinants in gastrointestinal disorders. Nat Rev Gastroenterol Hepatol 2015;12:472-85.
73. Halmos EP, Power VA, Shepherd SJ, et al. A diet low in FODMAPs reduces symptoms of irritable bowel syndrome. Gastroenterology 2014;146:67-75.
74. National Institute for Health and Care Excellence (NICE). Irritable bowel syndrome in adults: diagnosis and management of irritable bowel syndrome in primary care 2015. Retrieved from https://www.nice.org.uk/guidance/cg61 (accessed Aug 2016).
75. Böhn L, Störsrud S, Liljebo T, et al. Diet low in FODMAPs reduces symptoms of irritable bowel syndrome as well as traditional dietary advice: A randomized controlled trial. Gastroenterology 2015;149:1399-407.
76. Chumpitazi BP, Hollister EB, Oezguen N, et al. Gut microbiota influences low fermentable substrate diet efficacy in children with irritable bowel syndrome. Gut Microbes 2014;5:165-75.
77. Chumpitazi BP, Cope JL, Hollister EB, et al. Randomised clinical trial: gut microbiome biomarkers are associated with clinical response to a low FODMAP diet in children with the irritable bowel syndrome. Aliment Pharmacol Ther 2015;42:418-27.
78. Williams EA, Nai X, Corfe BM. Dietary intakes in people with irritable bowel syndrome. BMC Gastroenterol 2011;11:9.
79. Saito YA, Locke GR, Weaver AL, et al. Diet and functional gastrointestinal disorders: A population-based case-control study. Am J Gastroenterol 2005;100:2743-8.
80. Public Health England and Food Standards Agency. National Diet and Nutrition Survey: Appendices and tables. Retrieved from https://www.gov.uk/government/statistics/national-diet-And-nutrition-survey-results-from-years-1-To-4-combinedof-The-rolling-programme-for-2008-And-2009-To-2011-And-2012 (accessed Aug 2016).
81. Halmos EP, Christophersen CT, Bird AR, et al. Consistent prebiotic effect on gut microbiota with altered FODMAP intake in patients with crohns disease: A randomised, controlled cross-over trial of well-defined diets. Clin Transl Gastroenterol 2016;7:e164.
82. Png CW, Lindén SK, Gilshenan KS, et al. Mucolytic bacteria with increased prevalence in IBD mucosa augment in vitro utilization of mucin by other bacteria. Am J Gastroenterol 2010;105:2420-8.
83. Sokol H, Seksik P, Furet JP, et al. Low counts of Faecalibacterium prausnitzii in colitis microbiota. Inflamm Bowel Dis 2009;15:1183-9.
84. Halmos EP. A low FODMAP diet in patients with Crohns disease. J Gastroenterol Hepatol 2016;31:14-15.
85. Biesiekierski JR, Rosella O, Rose R, et al. Quantification of fructans, galactooligosacharides and other short-chain carbohydrates in processed grains and cereals. J Hum Nutr Diet 2011;24:154-76.
86. Prichard R, Rossi M, Muir J, et al. Fermentable oligosaccharide, disaccharide, monosaccharide and polyol content of foods commonly consumed by ethnic minority groups in the United Kingdom. Int J Food Sci Nutr 2016;67:383-90.
87. Muir JG, Rose R, Rosella O, et al. Measurement of short-chain carbohydrates in common Australian vegetables and fruits by high-performance liquid chromatography (HPLC). J Agric Food Chem 2009;57:554-65.
88. Pedersen N, Andersen NN, Végh Z, et al. Ehealth: low FODMAP diet vs Lactobacillus rhamnosus GG in irritable bowel syndrome. World J Gastroenterol 2014;20:16215-26.